Media release

DKSH Joins hands with Takeda to Expand the Coverage of Gastroenterology Products in Pharmacy Channel

DKSH Joins hands with Takeda to Expand the Coverage of Gastroenterology Products in Pharmacy Channel

A significant stride to uncover the unmet needs of Thai patients and to drive growth opportunities for both DKSH and Takeda.

Bangkok, August 15, 2022DKSH Business Unit Healthcare, Asia's leading partner for healthcare companies seeking to grow their business in Asia and beyond, has extended its partnership with Takeda (Thailand) Limited, a global, values-based, R&D-driven biopharmaceutical leader, to provide sales promotion in pharmacy channel operated in Thailand.

DKSH Thailand and Takeda Thailand have been working together for more than two decades to serving Thai patients with innovative medicines and healthcare solutions. The partnership is to reinforce Takeda’s leadership in the therapeutic area of gastroenterology, while leveraging DKSH’s large sales force, broad reach across the pharmacy channel, and strong ties with trade partners.

Peter Streibl, General Manager, Takeda Thailand, said "Gastroenterology is one of our core therapeutic areas where we are committed to addressing unmet medical needs for those living with gastrointestinal (GI) disease. We collaborate to form a partnership that makes the innovative treatments more accessible to those who are suffering with GI disease. Faithful to its commitment where the expansion into pharmacy channel is to solidify our leadership in gastroenterology, strengthen our presence in the market, and to support our long-standing commitment to resorting life to living for patients suffering with GI with innovative and life-transforming medicines.”

John Clare, Vice President Healthcare, DKSH Thailand & Indochina, commented “This partnership offers a great opportunity for us to expand our product portfolio to cover additional market segments and strengthen our position as a key player in Thailand’s pharmacy channel. Our extensive and experienced sales force along with our expertise in commercial outsourcing and tailored strategy to drive expansion will no doubt support Takeda to sustain its leadership position in this therapeutic area.”